Furthermore, our data implicate that inhibition of caspase-2 by TRIM25 protects tumor cells from chemotherapeutic drug-induced apoptosis and may constitute a novel mechanism of drug resistance in human colorectal carcinoma cells. This evidence concerns the gene CASP2 and colorectal carcinoma.